In its statement, GSK said the $30 billion investment would include capital investments in its U.S. supply chain and more ...

GSK plc (NYSE: GSK) appointed Luke Miels as the CEO Designate of GSK. He will assume full responsibility as CEO and join the ...

Emma Walmsley, who in 2017 became the first woman to lead a major pharmaceutical company, will step down from her post as CEO of GSK. She is to be succeeded by Luke Miels, who currently serves as ...

GSK names Luke Miels as next CEO, succeeding Emma Walmsley at a pivotal time as the drugmaker sets ambitious growth targets ...

British pharmaceutical firm GSK has pledged to invest $30bn (£22bn) in research and manufacturing in the US over the next ...

If you are weighing whether to jump into GSK or stick with what you have, you are definitely not alone. GSK’s stock is moving ...

GSK will invest $30 billion in U.S. R&D and manufacturing, including a new biologics factory, AI upgrades, and expanded drug ...

GSK, which has major operations in Philadelphia and Montgomery County, is making a change at the top. Join John George as he ...

The pharmaceutical company plans to break ground on a new manufacturing facility in Upper Merion, Pennsylvania, in 2026.

GSK commits $30 billion investment in U.S. R&D and manufacturing during Trump’s UK state visit, strengthening its focus on ...

GSK plans a $30 billion investment in US R&D and manufacturing, including $1.2 billion for advanced facilities and AI ...

As President Donald Trump started his state visit to the UK, GSK unveiled a massive $30 billion investment in manufacturing ...